National Vision Holdings Revenue 2015-2019 | EYE

National Vision Holdings revenue from 2015 to 2019. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
National Vision Holdings Annual Revenue
(Millions of US $)
2018 $1,537
2017 $1,375
2016 $1,196
2015 $1,063
2014 $933
National Vision Holdings Quarterly Revenue
(Millions of US $)
Q3 2019 $432
Q2 2019 $429
Q1 2019 $461
Q4 2018 $356
Q3 2018 $387
Q2 2018 $386
Q1 2018 $408
Q4 2017 $322
Q3 2017 $346
Q2 2017 $338
Q1 2017 $370
Q4 2016
Q3 2016 $301
Q4 2015
Q4 2014
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $2.677B $1.537B
National Vision Holdings, Inc. is involved in optical retail primarily in the United States. The company offer product and services for eye care needs through retail stores and consumer websites. Its brand portfolio consists of America's Best Contacts & Eyeglasses, Eyeglass World, Vision Centers inside select Walmart stores and Vista Optical locations inside Fred Meyer stores and on select military bases. National Vision Holdings, Inc. is headquartered in Duluth, Georgia.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $145.471B 19.56
Abbott Laboratories (ABT) United States $143.067B 25.04
Stryker (SYK) United States $77.279B 24.98
Boston Scientific (BSX) United States $55.628B 25.10
Baxter (BAX) United States $44.413B 26.93
Lonza Group Ag (LZAGY) Switzerland $31.143B 0.00
Zimmer Biomet Holdings (ZBH) United States $30.905B 19.02
EssilorLuxottica Societe Anonyme (ESLOY) France $30.846B 0.00
Coloplast (CLPBY) Denmark $28.771B 44.40
Terumo (TRUMY) Japan $24.654B 30.77
ResMed (RMD) United States $23.979B 41.66
Smith & Nephew SNATS (SNN) United Kingdom $20.809B 0.00
Sunny Optical Technology (SNPTF) China $18.147B 0.00
Insulet (PODD) United States $12.162B 756.65
Bio-Rad Laboratories (BIO) United States $11.027B 51.52
Perrigo (PRGO) Ireland $8.275B 15.43
William Demant Holdings (WILYY) Denmark $7.896B 0.00
GN STORE NORD (GNNDY) Denmark $7.537B 38.94
DiaSorin S.p.A (DSRLF) Italy $7.161B 0.00
Canopy Growth (CGC) Canada $6.854B 0.00
Hill-Rom Holdings (HRC) United States $6.850B 19.70
Haemonetics (HAE) United States $5.540B 34.10
Shandong Weigao Medical Polymer (SHWGF) China $5.020B 0.00
ICU Medical (ICUI) United States $4.217B 27.49
Envista Holdings (NVST) United States $4.210B 0.00
NuVasive (NUVA) United States $3.698B 28.59
GW Pharmaceuticals (GWPH) United Kingdom $3.616B 0.00
Neogen (NEOG) United States $3.531B 58.76
Quidel (QDEL) United States $3.256B 28.58
Hutchison China MediTech (HCM) Hong Kong, SAR China $3.224B 0.00
Agios Pharmaceuticals (AGIO) United States $3.200B 0.00
Aurora Cannabis (ACB) Canada $1.765B 0.00
AtriCure (ATRC) United States $1.553B 0.00
TG Therapeutics (TGTX) United States $1.410B 0.00
Cardiovascular Systems (CSII) United States $1.363B 0.00
NanoString Technologies (NSTG) United States $1.178B 0.00
InMode (INMD) Israel $1.076B 0.00
Phibro Animal Health (PAHC) United States $1.035B 20.47
Aphria (APHA) $1.023B 0.00
PetIQ (PETQ) United States $0.925B 22.57
VAREX IMAGING (VREX) United States $0.904B 18.79
Cerus (CERS) United States $0.795B 0.00
Quanterix (QTRX) United States $0.726B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.674B 25.82
Lantheus Holdings (LNTH) United States $0.655B 14.90
Omeros (OMER) United States $0.649B 0.00
DFB Healthcare Acquisitions (AHCO) United States $0.642B 122.46
LeMaitre Vascular (LMAT) United States $0.595B 33.84
MacroGenics (MGNX) United States $0.538B 0.00
Surmodics (SRDX) United States $0.493B 56.66
Zynex (ZYXI) United States $0.416B 47.11
Owens & Minor (OMI) United States $0.414B 15.33
Organigram Holdings (OGI) Canada $0.392B 0.00
OraSure Technologies (OSUR) United States $0.373B 46.54
HEXO (HEXO) $0.358B 0.00
Utah Medical Products (UTMD) United States $0.354B 25.16
Meridian Bioscience (VIVO) United States $0.319B 12.85
BioLife Solutions (BLFS) United States $0.311B 126.75
Evolus (EOLS) United States $0.290B 0.00
Female Health (VERU) United States $0.278B 0.00
Repro-Med Systems (KRMD) United States $0.272B 172.00
Bovie Medical (APYX) United States $0.243B 0.00
InfuSystems Holdings (INFU) United States $0.208B 1046.00
Rockwell Medical (RMTI) United States $0.199B 0.00
Neptune Wellness Solutions (NEPT) Canada $0.196B 0.00
Vapotherm (VAPO) United States $0.195B 0.00
Viemed Healthcare (VMD) United States $0.189B 19.92
Cytosorbents (CTSO) United States $0.184B 0.00
United Health Products (UEEC) United States $0.183B 0.00
Liberty Health Sciences (LHSIF) Canada $0.146B 0.00
Fonar (FONR) United States $0.129B 9.37
Chimerix (CMRX) United States $0.123B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.121B 0.00
MTech Acquisition (KERN) United States $0.099B 0.00
Surface Oncology (SURF) United States $0.094B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.087B 0.00
United-Guardian (UG) United States $0.074B 18.77
Nephros (NEPH) United States $0.070B 0.00
Chembio Diagnostics (CEMI) United States $0.067B 0.00
FSD PHARMA INC (HUGE) Canada $0.044B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
NF Energy Saving (BIMI) China $0.036B 0.00
Trinity Biotech (TRIB) Ireland $0.023B 0.00
GUARDION HEALTH (GHSI) United States $0.022B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.014B 0.00
Senestech (SNES) United States $0.006B 0.00
Capricor Therapeutics (CAPR) United States $0.006B 0.00
Myomo (MYO) United States $0.003B 0.00
NeuroMetrix (NURO) United States $0.003B 0.00
Akers Biosciences Inc (AKER) United States $0.002B 0.00